Evidence map›Paper›PMID 35389157›Full record

ArticleClinical and experimental medicine2023

The latest research trends in primary biliary cholangitis: a bibliometric analysis.

Yu Zhao, Zhenjie Yin, Huang Du, Kangming Huang, Fajing Zhang, Hongbin Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yu Zhao *Department of Gastroenterology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China.
Zhenjie Yin *Department of Urology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China.
Huang DuDepartment of Gastroenterology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China.
Kangming HuangDepartment of Gastroenterology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China.
Fajing ZhangDepartment of Gastroenterology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China.
Hongbin ChenDepartment of Gastroenterology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, 365001, Fujian, People's Republic of China. smchb2008@qq.com.ORCID http://orcid.org/0000-0002-8956-6814
Fujian Medical University · CN

Funding

Natural Science Foundation of Fujian Province 2020J01120297
6 · The paper itself

Abstract

The bibliometric analysis uses the citation count of an article to measure its impact in the scientific community, but no study has been undertaken to determine the most influential papers in the field of primary biliary cholangitis (PBC). This study aimed to investigate the global research interest regarding PBC in dentistry using a bibliometric approach. We searched the Web of Science Core Collection database to find the top 100 most cited (T100) articles focusing on PBC. The information about each article including citations, authors, journals, countries, institutions, and keywords was recorded for bibliometric analysis. The T100 articles related to PBC were published from 1983 to 2019 and were originated from 26 countries. A total of 805 different authors were from 342 different institutions, and articles written by them were published in 35 journals. The five most frequently occurring keywords were "biochemical response," "ursodeoxycholic acid," "primary biliary cirrhosis," "antimitochondrial antibody," and "autoimmunity." The T100 articles were classified into different research focuses: pathogenesis (41%), treatment (20%), prognosis (12%), epidemiology (9%), diagnosis (8%), and others (10%). These 100 articles included 32 observational studies, 29 basic research articles, 15 reviews, eight meta-analyses, 12 clinical trials, and four clinical guidelines. The 100 top-cited articles are marked with the leading countries, institutions, journals, hotspots, and development trends in the PBC field that could provide the foundation for further investigations.

Indexed as

Liver Cirrhosis, BiliaryBibliometricsHumansMeta-Analysis as TopicObservational Studies as TopicBibliometricCitation analysisPrimary biliary cholangitisPrimary biliary cirrhosis

Identifiers

PMID35389157
OpenAlexW4225811032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.